Last updated: 2026-09-08 16:49:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
MIRA Pharmaceuticals, Inc. (MIRA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.79, with a market capitalization of $32.10M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.60 to $2.45. This page covers its latest market performance, valuation, price trends and company information.
$32.10M | |
$0.76 | |
$7.98 | |
$0.51 | |
$0.76 | |
123.92K | |
561.43K | |
-- | |
$2.45 | |
$0.60 | |
-- | |
-- |
MIRA Pharmaceuticals, Inc. (MIRA) is currently trading at $0.79 as of 2026-09-08 16:45:00, up 3.30% ($0.03) from the previous close of $0.76
During today's regular trading session, MIRA has traded between $0.51 and $7.98, with a trading volume of 123.92K shares. The current price is near the lower end of today's range.
Over the past seven days, MIRA Pharmaceuticals, Inc. (MIRA) moved from $0.77 to $0.79, representing a gain of 2.45% ($0.02).
The stock traded between $0.72 and $1.10 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 4.40 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 10.2%
MIRA is currently trading at $0.79, placing it 10.2% of the way from its 52-week low of $0.60 to its 52-week high of $2.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of MIRA Pharmaceuticals, Inc. (MIRA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.